Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02869113 · ClinicalTrials.gov registry record · NA
Evaluation of the Stinging Potential of Sunscreen Products in Human Eyes
A NA study, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT02869113 is a NA study that has completed, run by Bayer. The registered enrollment target is 65 participants.
The verdict
NCT02869113, a NA study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
The objective of this study was to compare the human eye stinging potential of experimental formulas and an industry standard shampoo mixture. The study was conducted under the supervision of a Board Certified Ophthalmologist.
Interventions
- DRUG BAY98751 (Y65-110)
- DRUG BAY 98751 (Y65-102)
- DRUG BAY 98751 (Y65-106)
- DRUG Standard shampoo mixture (Control)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2015-01-23 |
| Est. Completion | 2015-01-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02869113
The ClinicalTrials.gov registry entry for NCT02869113 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which BAY98751 (Y65-110) is the first listed.
NCT02869113 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02869113 about?
NCT02869113 is a clinical study titled "Evaluation of the Stinging Potential of Sunscreen Products in Human Eyes". The objective of this study was to compare the human eye stinging potential of experimental formulas and an industry standard shampoo mixture. The study was conducted under the supervision of a Board Certified Ophthalmologist.
What is the current status of trial NCT02869113?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2015-01-23. Estimated completion is 2015-01-24.
What interventions are being tested in trial NCT02869113?
The interventions under investigation include: BAY98751 (Y65-110) (DRUG), BAY 98751 (Y65-102) (DRUG), BAY 98751 (Y65-106) (DRUG), Standard shampoo mixture (Control) (DRUG).
Who is sponsoring clinical trial NCT02869113?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.